Leonard L. Mazur, Executive Chairman at Citius Pharmaceuticals, Inc. (CTXR), bought 335,008 shares at $2.99 ($1.0M) on 2018-03-29, disclosed to the SEC on 2018-04-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 167,504 | $501K | 50.0% |
| 2 | $2.99 | 167,504 | $501K | 50.0% |
| Total | $2.99 avg | 335,008 | $1.0M | 100% |
| Filing → |
| CTXR | BUY | 2019-04-05 | $3.6M | — | Filing → |
| CTXR | BUY | 2018-08-15 | $8.0M | — | Filing → |
| CTXR | BUY | 2018-01-08 | $2.0M | — | Filing → |